
The global Animal Antibiotics and Antimicrobials market is projected to reach US$ 4840.5 million in 2029, increasing from US$ 3934.2 million in 2022, with the CAGR of 2.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Animal Antibiotics and Antimicrobials 91ÖÆÆ¬³§.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 25%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Animal Antibiotics and Antimicrobials market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Zoetis, Inc.
Merck & Co., Inc.
Eli Lilly and Company
Bayer AG
Virbac
Boehringer Ingelheim GmbH
Sanofi
Ceva Sante Animale
Vetoquinol S.A.
Dechra Pharmaceuticals PLC
Segment by Type
Etracyclines
Penicillins
Macrolides
Aminoglycosides
Sulfonamides
Fluoroquinolones
Lincosamides
Cephalosporins
Others
Segment by Application
Food-producing Animals
Companion Animals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Animal Antibiotics and Antimicrobials report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Antibiotics and Antimicrobials Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Etracyclines
1.2.3 Penicillins
1.2.4 Macrolides
1.2.5 Aminoglycosides
1.2.6 Sulfonamides
1.2.7 Fluoroquinolones
1.2.8 Lincosamides
1.2.9 Cephalosporins
1.2.10 Others
1.3 Market by Application
1.3.1 Global Animal Antibiotics and Antimicrobials Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Food-producing Animals
1.3.3 Companion Animals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Antibiotics and Antimicrobials Market Perspective (2018-2029)
2.2 Animal Antibiotics and Antimicrobials Growth Trends by Region
2.2.1 Global Animal Antibiotics and Antimicrobials Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Animal Antibiotics and Antimicrobials Historic Market Size by Region (2018-2023)
2.2.3 Animal Antibiotics and Antimicrobials Forecasted Market Size by Region (2024-2029)
2.3 Animal Antibiotics and Antimicrobials Market Dynamics
2.3.1 Animal Antibiotics and Antimicrobials Industry Trends
2.3.2 Animal Antibiotics and Antimicrobials Market Drivers
2.3.3 Animal Antibiotics and Antimicrobials Market Challenges
2.3.4 Animal Antibiotics and Antimicrobials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Antibiotics and Antimicrobials Players by Revenue
3.1.1 Global Top Animal Antibiotics and Antimicrobials Players by Revenue (2018-2023)
3.1.2 Global Animal Antibiotics and Antimicrobials Revenue Market Share by Players (2018-2023)
3.2 Global Animal Antibiotics and Antimicrobials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Animal Antibiotics and Antimicrobials Revenue
3.4 Global Animal Antibiotics and Antimicrobials Market Concentration Ratio
3.4.1 Global Animal Antibiotics and Antimicrobials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Antibiotics and Antimicrobials Revenue in 2022
3.5 Animal Antibiotics and Antimicrobials Key Players Head office and Area Served
3.6 Key Players Animal Antibiotics and Antimicrobials Product Solution and Service
3.7 Date of Enter into Animal Antibiotics and Antimicrobials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Antibiotics and Antimicrobials Breakdown Data by Type
4.1 Global Animal Antibiotics and Antimicrobials Historic Market Size by Type (2018-2023)
4.2 Global Animal Antibiotics and Antimicrobials Forecasted Market Size by Type (2024-2029)
5 Animal Antibiotics and Antimicrobials Breakdown Data by Application
5.1 Global Animal Antibiotics and Antimicrobials Historic Market Size by Application (2018-2023)
5.2 Global Animal Antibiotics and Antimicrobials Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Animal Antibiotics and Antimicrobials Market Size (2018-2029)
6.2 North America Animal Antibiotics and Antimicrobials Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Animal Antibiotics and Antimicrobials Market Size by Country (2018-2023)
6.4 North America Animal Antibiotics and Antimicrobials Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Antibiotics and Antimicrobials Market Size (2018-2029)
7.2 Europe Animal Antibiotics and Antimicrobials Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Animal Antibiotics and Antimicrobials Market Size by Country (2018-2023)
7.4 Europe Animal Antibiotics and Antimicrobials Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Antibiotics and Antimicrobials Market Size (2018-2029)
8.2 Asia-Pacific Animal Antibiotics and Antimicrobials Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Animal Antibiotics and Antimicrobials Market Size by Region (2018-2023)
8.4 Asia-Pacific Animal Antibiotics and Antimicrobials Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Antibiotics and Antimicrobials Market Size (2018-2029)
9.2 Latin America Animal Antibiotics and Antimicrobials Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Animal Antibiotics and Antimicrobials Market Size by Country (2018-2023)
9.4 Latin America Animal Antibiotics and Antimicrobials Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Antibiotics and Antimicrobials Market Size (2018-2029)
10.2 Middle East & Africa Animal Antibiotics and Antimicrobials Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Animal Antibiotics and Antimicrobials Market Size by Country (2018-2023)
10.4 Middle East & Africa Animal Antibiotics and Antimicrobials Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis, Inc.
11.1.1 Zoetis, Inc. Company Detail
11.1.2 Zoetis, Inc. Business Overview
11.1.3 Zoetis, Inc. Animal Antibiotics and Antimicrobials Introduction
11.1.4 Zoetis, Inc. Revenue in Animal Antibiotics and Antimicrobials Business (2018-2023)
11.1.5 Zoetis, Inc. Recent Development
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Detail
11.2.2 Merck & Co., Inc. Business Overview
11.2.3 Merck & Co., Inc. Animal Antibiotics and Antimicrobials Introduction
11.2.4 Merck & Co., Inc. Revenue in Animal Antibiotics and Antimicrobials Business (2018-2023)
11.2.5 Merck & Co., Inc. Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Detail
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Animal Antibiotics and Antimicrobials Introduction
11.3.4 Eli Lilly and Company Revenue in Animal Antibiotics and Antimicrobials Business (2018-2023)
11.3.5 Eli Lilly and Company Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Detail
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Animal Antibiotics and Antimicrobials Introduction
11.4.4 Bayer AG Revenue in Animal Antibiotics and Antimicrobials Business (2018-2023)
11.4.5 Bayer AG Recent Development
11.5 Virbac
11.5.1 Virbac Company Detail
11.5.2 Virbac Business Overview
11.5.3 Virbac Animal Antibiotics and Antimicrobials Introduction
11.5.4 Virbac Revenue in Animal Antibiotics and Antimicrobials Business (2018-2023)
11.5.5 Virbac Recent Development
11.6 Boehringer Ingelheim GmbH
11.6.1 Boehringer Ingelheim GmbH Company Detail
11.6.2 Boehringer Ingelheim GmbH Business Overview
11.6.3 Boehringer Ingelheim GmbH Animal Antibiotics and Antimicrobials Introduction
11.6.4 Boehringer Ingelheim GmbH Revenue in Animal Antibiotics and Antimicrobials Business (2018-2023)
11.6.5 Boehringer Ingelheim GmbH Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Animal Antibiotics and Antimicrobials Introduction
11.7.4 Sanofi Revenue in Animal Antibiotics and Antimicrobials Business (2018-2023)
11.7.5 Sanofi Recent Development
11.8 Ceva Sante Animale
11.8.1 Ceva Sante Animale Company Detail
11.8.2 Ceva Sante Animale Business Overview
11.8.3 Ceva Sante Animale Animal Antibiotics and Antimicrobials Introduction
11.8.4 Ceva Sante Animale Revenue in Animal Antibiotics and Antimicrobials Business (2018-2023)
11.8.5 Ceva Sante Animale Recent Development
11.9 Vetoquinol S.A.
11.9.1 Vetoquinol S.A. Company Detail
11.9.2 Vetoquinol S.A. Business Overview
11.9.3 Vetoquinol S.A. Animal Antibiotics and Antimicrobials Introduction
11.9.4 Vetoquinol S.A. Revenue in Animal Antibiotics and Antimicrobials Business (2018-2023)
11.9.5 Vetoquinol S.A. Recent Development
11.10 Dechra Pharmaceuticals PLC
11.10.1 Dechra Pharmaceuticals PLC Company Detail
11.10.2 Dechra Pharmaceuticals PLC Business Overview
11.10.3 Dechra Pharmaceuticals PLC Animal Antibiotics and Antimicrobials Introduction
11.10.4 Dechra Pharmaceuticals PLC Revenue in Animal Antibiotics and Antimicrobials Business (2018-2023)
11.10.5 Dechra Pharmaceuticals PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Zoetis, Inc.
Merck & Co., Inc.
Eli Lilly and Company
Bayer AG
Virbac
Boehringer Ingelheim GmbH
Sanofi
Ceva Sante Animale
Vetoquinol S.A.
Dechra Pharmaceuticals PLC
Ìý
Ìý
*If Applicable.
